Molina-Moya, Barbara
Agonafir, Mulualem
Blanco, Silvia
Dacombe, Russell
Gomgnimbou, Michel K.
Spinasse, Lizania
Gomes-Fernandes, Meissiner
Datiko, Daniel G.
Edwards, Thomas
Cuevas, Luis E. http://orcid.org/0000-0002-6581-0587
Dominguez, Jose
Sola, Christophe
Article History
Received: 3 July 2017
Accepted: 15 February 2018
First Online: 5 March 2018
Competing Interests
: M.K. Gomgnimbou and C. Sola are among the founders of the Beamedex SAS company that produces and commercializes the spoligotyping (TB-SPOL) kit as a “Research Use Only” assay, to be run on Luminex 200 and on MagPix devices (Luminex Corp., Austin, TX). These authors held Beamedex shares during the study. However, C. Sola does not hold any share in Beamedex anymore. M.K. Gomgnimbou and C. Sola also declare that they do not hold any share in Luminex Corporation nor were financed by Luminex. The other investigators have no financial interest or financial conflict with the subject matter or materials discussed in this report.